Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 5, May, p. 717–723

doi: 10.17219/acem/68386

Publication type: review article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

The expression of marker genes during the differentiation of mesenchymal stromal cells

Aleksandra Zołocińska1,A,B,C,D,E,F

1 Department of Regenerative Medicine, Maria Skłodowska-Curie Memorial Cancer Center, Warszawa, Poland


Mesenchymal stromal cells (MSCs) are an excellent and easily accessible source of precursor cells that have applications in regenerative medicine. They can be obtained from almost any tissue; however, bone marrow, Wharton’s jelly and adipose tissue are the most frequently used sources of MSCs. Increased interest in using MSCs in medical procedures has resulted in a pressing need to identify the genetic elements that can indicate the presence and the characteristics of MSCs. Genomic profiling enables the identification and characterization of MSCs as well as finding biomarkers and key molecules involved in all processes occurring in the cell. This knowledge is essential for developing a stem cell approach for tissue engineering and can improve the development of new clinical applications of MSCs. This review is an attempt to give an overview of key genetic markers indicating the main directions of MSC differentiation. The expression of these genes provides information about the direction and progress of differentiation and about interactions with the surrounding environment as well as specific molecular pathways that MSCs are involved in.

Key words

gene expression, mesenchymal stem cells, regenerative medicine, genetic markers

References (39)

  1. Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393–395.
  2. Safford KM, Hicok KC, Safford SD, et al. Neurogenic differentiation of murine and human adipose – derived stroll cells. Biochem Biophys Res Commun. 2002;294:371–379.
  3. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93–98.
  4. Chen LB, Jiang XB, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol. 2004;10:3016–3020.
  5. Ji R, Zhang N, You N, et al. The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice. Biomaterials. 2012;33:8995–9008.
  6. Pojda Z, Machaj E, Kurzyk A, et al. Mesenchymal stem cells. Postepy Biochem. 2013;59(2):187–197.
  7. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoetic organs. Exp Hematol. 1976;4:267–274.
  8. Saulnier N, Puglisi MA, Lattanzi W, et al. Gene profiling of bone marrow- and adipose tissue-derived stromal cells: A key role of Kruppel-like factor 4 in cell fate regulation. Cytotherapy. 2011;13:329–340.
  9. Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: Ten years of research and literature review. J Nippon Med Sch. 2009;76(2):56–66.
  10. Włodarski K, Włodarski P, Galus R, Mazur S. Adipose mesenchymal stem cells. Their characteristics and potential application in tissue repair. Pol Orthop Traumatol. 2012;77:97–99.
  11. Graneli C, Thorfve A, Ruetschi U, et al. Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach. Stem Cell Res. 2014;12:153–165.
  12. Huang SJ, Fu RH, Shyu WC, et al. Adipose-derived stem cells: Isolation, characterization, and differentiation potential. Cell Transplant. 2013;22:701–709.
  13. Luongo de Matos L, Trufelli DC, Luongo de Matos MG, da Silva Pinhal MA. Immunohistochemistry as an important tool in biomarkers detection and clinical practice. Biomark Insights. 2010;5:9–20.
  14. Bae S, Ahn JH, Park CW, et al. Gene and microRNA expression signatures of human mesenchymal stromal cells in comparison to fibroblasts. Cell Tissue Res. 2009;335:565–573.
  15. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996;6:986–994.
  16. Walder RY, Wattiez AS, White SR, de Prado BM, Hamity MV, Hammond DL. Validation of four reference genes for quantitative mRNA expression studies in a rat model of inflammatory injury. Mol Pain. 2014;10:55.
  17. Wu L, Cai X, Zhang S, Karperien M, Lin Y. Regeneration of articular cartilage by adipose tissue derived mesenchymal stem cells: Perspectives from stem cell biology and molecular medicine. J Cell Physiol. 2013;228;938–944.
  18. Taha MF, Hedayati V. Isolation, identification and multipotential differentiation of mouse adipose tissue-derived stem cells. Tissue Cell. 2010;42:211–216.
  19. Graneli C, Karlsson C, Brisby H, Lindahl A, Thomsen P. The effects of PPAR-γ inhibition on gene expression and the progression of induced osteogenic differentiation of human mesenchymal stem cells. Connect Tissue Res. 2014;55(4):262–274.
  20. Ntambi JM, Kim YC. Adipocyte differentiation and gene expression. J Nutr. 2000;130:3122S–3126S.
  21. Hu E, Liang P, Spiegelman BM. AdipoQ Is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996;271(18):10697–10703.
  22. Sila-Asna M, Bunyaratvej A, Maeda S, Kitaguchi H, Bunyaratvej N. Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell. Kobe J Med Sci. 2007;53(1–2):25–35.
  23. Qi H, Aguiar DJ, Williams SM, La Pean A, Pan W, Verfaillie CM. Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci U S A. 2003;100(6);3305–3310.
  24. Prince M, Banerjee C, Javed A, et al. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem. 2001;80:424–440.
  25. Marom R, Shur I, Solomon R, Benayahu D. Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells. J Cell Physiol. 2005;202:41–48.
  26. Mizuno M, Kuboki Y. Osteoblast – related gene expression of bone marrow cells during the osteoblastic differentiation induced by type I collagen. J Biochem. 2001;129:133–138.
  27. Tsai MT, Li WJ, Tuan RS, Chang WH. Modulation of osteogenesis in human mesenchymal stem cells by specific pulsed electromagnetic field stimulation. J Orthop Res. 2009;27(9):1169–1174.
  28. Eid AA, Hussein KA, Niu LN, et al. Effects of tricalcium silicate on osteogenic differentiation of human bone marrow-derived mesenchymal stem cells in vitro. Acta Biomater. 2014;10:3327–3334.
  29. Gordon JAR, Tye CE, Sampaio AV, Underhill TM, Hunter GK, Goldberg HA. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone. 2007;41:462–473.
  30.; Published May 1, 1991. Updated February 28, 2018. Accessed April 15, 2018.
  31. Maes C, Kobayashi T, Selig MK, et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell. 2010;19:329–344.
  32. Hamid AA, Idrus RBH, Saim AB, Sathappan S, Chua KH. Characterization of human adipose-derived stem cells and expression of chondrogenic genes during induction of cartilage differentiation. Clinics. 2012;67(2);99–106.
  33. de Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S, Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 2000;19:389–394.
  34. Lin Y, Luo E, Chen X, at al. Molecular and cellular characterization during chondrogenic differentiation of adipose tissue-derived stromal cells in vitro and cartilage formation in vivo. J Cell Mol Med. 2005;9(4):929–939.
  35. Mwale F, Stachura D, Roughley P, Antoniou J. Limitations of using aggrecan and type X collagen as markers of chondrogenesis in mesenchymal stem cell differentiation. J Orthop Res. 2006;24:1791–1798.
  36. Burk J, Gittel C, Heller S, at al. Gene expression of tendon markers in stromal cells derived from different sources. BMC Res Notes. 2014;7:826.
  37. An Y, Reimers K, Allmeling C, Liu J, Lazaridis A, Vogt PM. Validation of differential gene expression in muscle engineered from rat groin adipose tissue by quantitative real-time PCR. Biochem Biophys Res Commun. 2012;421:736–742.
  38. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001;7:211–226.
  39. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279–4295.